Reviva Pharmaceuticals Holdings, Inc.

RVPH · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$13,476$23,367$18,520$29,688
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,207$333$404$1,716
Total Curr. Assets$14,683$23,700$18,924$31,404
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$820$0$403,819$1,716
Total NC Assets$820$0$403,819$1,716
Other Assets$0$0-$403,819-$1,716
Total Assets$15,503$23,700$18,924$31,404
Liabilities
Payables$6,283$3,849$3,520$510
Short-Term Debt$458$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,860$13,326$6,442$1,835
Total Curr. Liab.$14,602$17,175$9,962$2,345
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$89$807$567$373
Total NC Liab.$89$807$567$373
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$14,691$17,982$10,529$2,718
Equity
Pref Stock$0$0$0$0
Common Stock$5$3$2$1
Retained Earnings-$164,273-$134,354-$95,093-$66,832
AOCI$0$0$0$0
Other Equity$165,081$140,070$103,486$95,517
Total Equity$813$5,719$8,394$28,686
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,503$23,700$18,924$31,404
Net Debt-$13,018-$23,367-$18,520-$29,688